JG
RCEL icon

Jain Global’s Avita Medical RCEL Stock Holding History

Jain Global’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,168
Closed -$83.4K – 1567
2025
Q4 		$83.4K Buy
+24,168
New +$96.4K ﹤0.01% 1122

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jain Global's RCEL Position: Q1 2026 in Review

Jain Global sold out of Avita Medical (RCEL) in Q1 2026, closing a stake of 24,168 shares — an estimated $83.4K sold.

Jain Global first reported a position in RCEL in Q4 2025 and held it in 1 quarter. The position peaked at $83.4K in Q4 2025. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • Jain Global reported no remaining Avita Medical position as of Q1 2026 after selling out during the quarter.
  • Jain Global sold 24,168 Avita Medical shares in Q1 2026, an estimated $83.4K.
  • Jain Global first reported a position in Avita Medical in Q4 2025 and held it in 1 quarter.
  • Jain Global's Avita Medical position peaked at $83.4K in Q4 2025.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.